Ola Winqvist
Chief Executive Officer at ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Ola Winqvist active positions
Companies | Position | Start | End |
---|---|---|---|
ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Chief Executive Officer | 31/12/2017 | - |
Founder | 16/09/2015 | - | |
Investor Relations Contact | 16/09/2015 | - | |
Chief Tech/Sci/R&D Officer | 16/09/2015 | - | |
Karolinska Institutet | Corporate Officer/Principal | - | - |
TLA Targeted Immunotherapies AB
TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Director/Board Member | - | - |
ImmunoWise AB | Chairman | - | - |
Svenska Läkaresällskapet | Chairman | - | - |
Career history of Ola Winqvist
Former positions of Ola Winqvist
Companies | Position | Start | End |
---|---|---|---|
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Director/Board Member | 31/12/2003 | 30/12/2012 |
Founder | 25/11/2009 | 30/12/2012 | |
Goodwill Industries of North Louisiana, Inc.
Goodwill Industries of North Louisiana, Inc. Services to the Health IndustryHealth Services Goodwill Industries of North Louisiana, Inc. provides vocational programs and employment services for people with disabilities and in disadvantaged conditions. It offers multiple job resource centers, equipped with job-search experts, computers, Internet access and telephones. The firm also offers programs and contract services. The company was founded in 1926 and is headquartered in Shreveport, LA. | Director/Board Member | - | - |
Training of Ola Winqvist
University of Uppsala | Doctorate Degree |
Statistics
International
Sweden | 8 |
United States | 2 |
Operational
Director/Board Member | 3 |
Founder | 2 |
Chairman | 2 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
Goodwill Industries of North Louisiana, Inc.
Goodwill Industries of North Louisiana, Inc. Services to the Health IndustryHealth Services Goodwill Industries of North Louisiana, Inc. provides vocational programs and employment services for people with disabilities and in disadvantaged conditions. It offers multiple job resource centers, equipped with job-search experts, computers, Internet access and telephones. The firm also offers programs and contract services. The company was founded in 1926 and is headquartered in Shreveport, LA. | Health Services |
TLA Targeted Immunotherapies AB
TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Electronic Technology |
ISR Immune System Regulation Holding AB
ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
Svenska Läkaresällskapet | |
ImmunoWise AB |
- Stock Market
- Insiders
- Ola Winqvist
- Experience